Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Adicet Bio, Inc.

NASDAQ: ACET · Life Sciences · 4 alerts · CIK 1720580

Share price
$2.75Close, Nov 16
Market cap
$25.7M
Shares outstanding
9.36MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Adicet Bio, Inc. filings on SEC EDGAR ↗

4:17 PM ET 8-K
Financial Results

Adicet Bio Financial Results

Adicet Bio reported third quarter 2026 financial results and provided updates on its clinical pipeline, including positive Phase 1 data for prula-cel in systemic lupus erythematosus. The company ended the quarter with $204.4 million in cash and cash equivalents, providing a projected runway into the second half of 2027.

Term
Q3 2026

“The growing body of evidence for prula-cel continues to strengthen our conviction in its potential to generate meaningful, lasting remissions for patients living with SLE, including those with LN and extra renal SLE. The compelling efficacy observed following complete discontinuation of immunosuppressants, together with evidence of a deep immune reset and a favorable safety profile supporting outpatient administration, reinforce the potential for prula-cel to meaningfully change the treatment paradigm for lupus patients.”

Chen Schor, President and Chief Executive Officer of Adicet Bio
4:17 PM ET 10-Q
Financial Results

Adicet Bio Q3 2026 Results: Net Loss of $18.9M, Loss Narrows

Adicet Bio, Inc. is a clinical-stage biotechnology company focused on gamma delta T cell therapies for autoimmune diseases and cancer, with its lead candidate prula-cel (ADI-001) currently in Phase 1 trials. The company reported 9,361,596 shares of common stock outstanding as of November 3, 2026, and highlighted significant risks including the need for substantial additional financing and reliance on third-party manufacturing.

Key figure
Net loss $18.9M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.